Ninety One UK 13F: Adds $60M to UnitedHealth (UNH) Stake

Institutional investor Ninety One UK grew its stake in UnitedHealth Group Incorporated (NYSE: UNH) during the period, according to a Form 13F filing submitted to the Securities and Exchange Commission on October 15, 2026. Because 13F filings look backward at holdings from the end of the reported quarter, the figures show the fund's position at that time and may not reflect its current holdings today.

What Changed in Ninety One UK's UnitedHealth Group Incorporated Position

Ninety One UK lifted its holdings in UnitedHealth Group Incorporated by a 14.8% margin, purchasing an additional 163,350 shares during the period. That addition brought the fund's total stake to 1,266,720 shares. The reported value of the position stood at $464,987,588.

Other Institutional Activity in UnitedHealth Group Incorporated

Other major institutional investors also adjusted their positions in UnitedHealth Group Incorporated around the same reporting cycle. Blackrock Inc. grew its holdings by 3,394,259 shares, ending with 76,863,061 shares worth about $30,855,138,014. Vanguard Capital Management LLC grew its holdings by 441,525 shares, ending with 59,311,525 shares worth about $23,809,425,046. State Street Corporation grew its holdings by 299,205 shares, ending with 45,633,267 shares worth about $18,318,562,037. Capital World Investors grew its holdings by 2,103,297 shares, ending with 29,887,932 shares worth about $11,997,912,323. FMR, LLC grew its holdings by 15,974,192 shares, ending with 27,992,995 shares worth about $11,237,227,777.

UnitedHealth Group Incorporated Stock Up 1.7%

UnitedHealth Group Incorporated recently traded around $402.35 as of October 16, 2026. The stock sits about 12.8% below its 52-week high of $461.62 and well above its 52-week low of $255.97. The shares are also trading roughly 3.9% above their 50-day moving average of $387.35 and 12.2% above their 200-day moving average of $358.75.

Recent Earnings

UnitedHealth Group Incorporated reported trailing-twelve-month revenue of $450,059,010,048 along with earnings of $15.55 per share. The company posted a net profit margin of 3.5% and a return on equity of 15.8%. Its year-over-year revenue growth stood at a 0.4% decline. The company's next earnings report is scheduled for January 26, 2027.

Dividend

UnitedHealth Group Incorporated offers an annualized dividend yield of 2.28%, backed by a payout ratio of 57.6%.

Insider Buying and Selling at UnitedHealth Group Incorporated

Company insiders also transacted in shares during the months leading up to the filing. Officer Patrick Hugh Conway sold 500 shares on August 5, 2026, at an average price of $410.00 for a total value of $205,000. Later, on August 21, 2026, Conway sold an additional 1,169 shares at an average price of $390.00 for a total value of $455,910.

Analysts Set New Price Targets

Wall Street analysts have updated their views on UnitedHealth Group Incorporated recently. On October 9, 2026, TD Cowen maintained its Hold rating and set a $402.00 price target. On October 14, 2026, Piper Sandler maintained an Overweight rating with a $504.00 price target. Barclays maintained an Overweight rating with a $440.00 price target on the same day. Baird also maintained a Neutral rating on October 14, 2026, with a $427.00 price target. TD Cowen later reiterated its Hold rating with a $402.00 target on October 15, 2026. Across the broader analyst community, the stock carries a consensus buy rating with a mean target price of $477.04 derived from 25 analyst opinions.

About UnitedHealth Group Incorporated

UnitedHealth Group Incorporated is a major health care company in the United States. It operates through segments focused on health insurance, care delivery, wellness programs, and pharmacy services. The company provides health care coverage and services to individuals, employers, and public-sector entities across the country.

Bottom Line

Ninety One UK's increased stake reflects confidence from the institutional investor during the reporting period. Observers will look toward the company's next earnings release on January 26, 2027, for further updates on financial performance.